Skip to main content
. 2022 Feb 8;130(6):764–775. doi: 10.1111/bju.15697

Fig. 1.

Fig. 1

Treatment of patients younger than 75 years (A) and 75 years and older (B) diagnosed with non‐metastatic muscle‐invasive bladder cancer over time (2005–2019). * Data from 2019 are provisional (97% complete). ** Chemoradiotherapy was defined as concurrent treatment with chemotherapy and radiotherapy, i.e. both treatments should start at the same date or show overlap between treatment periods. *** Other includes: partial cystectomy, systemic chemotherapy, immunotherapy, combination therapy. NAC, neoadjuvant chemotherapy.